
Will your own immune system be the cure to your own cancer?
Recently a deal between the biopharmaceutical companies Gilead and Kite Pharma was announced. Under the agreement, Gilead will buy Kite for a stunning USD 11 billion, shifting the focus of Gilead from infectious diseases to the field of oncology, just like that. But why write a post on MI about such apparently business-related issue? Kite […]